Sandra Allen-Bard on Advocating for Patients with Leukemia and Lymphoma

Video

Sandra Allen-Bard discusses her passion for advocacy involvement with the Leukemia & Lymphoma Society.

Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses her involvement in advocacy groups.

Working as a nurse for patients with leukemia for over 20 years, Allen-Bard has gained a passion in seeing how life-altering this diagnosis can be. She believes that research needs to continue as there are different pathways to discover. With the Leukemia & Lymphoma Society, Allen-Bard can use her running, education, and her voice to help her patients in just one more way.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Related Content
Graphic of red blood cells

Frontline Ibrutinib/Venetoclax Yields Response in Older Patients With MCL

Kyle Doherty
June 26th 2025
Article

The frontline combination of ibrutinib with venetoclax was associated with complete response and durable remission for older patients with MCL.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Graphic of bone marrow cells with cancer

Anemia Protocol Does Not Reduce Ruxolitinib Efficacy in Myelofibrosis

Ariana Pelosci
June 20th 2025
Article

Adding danazol or erythropoiesis-stimulating agents for anemia management to a ruxolitinib regimen for myelofibrosis does not decrease treatment efficacy.

Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL

Lindsay Fischer
December 1st 2023
Podcast

Laura Zitella, MS, RN, ACNP-BC, AOCN, discusses how newly approved bispecific antibodies are expanding third-line treatment options for patients with diffuse large B-cell lymphoma.

Line illustration of a clipboard that says "FDA" with an approval mark in front on a cornflower blue background

A Snapshot of April FDA Approvals in Oncology for Nurses and APPs

Bridget Hoyt
May 1st 2025
Article

Approvals in oncology during April included treatments for breast cancer, colorectal cancer, and more.

Line illustration of red blood cells on a yellow background

Blinatumomab-Linked ICANS Cases Higher Than Previously Reported

Russ Conroy
April 20th 2025
Article

Using tools like the ICE Score could improve consistency in grading neurotoxicity tied to bispecific antibodies in hematologic cancers.